Effects of Brain-Derived Neurotrophic Factor (BDNF) on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-induced Parkinsonism in Monkeys

脑源性神经营养因子 (BDNF) 对 1-甲基-4-苯基-1,2,3,6-四氢吡啶 (MPTP) 诱导的猴帕金森病的影响

基本信息

项目摘要

The effects of intrathecal infusion of brain-derived neurotrophic factor (BDNF) were examined in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine (MPTP)-induced parkinsonian model in monkeys. Nine Japanese monkeys were divided randomly into three groups : untreated control (n=3) ; BDNF group (n=3) ; and non-BDNF group(n=3). Animals in the BDNF group reccived continuous intrathecal infusion of 10 ml of cell culture medium containing a total of 10 mug of BDNF protein ; while the non-BDNF group reccived intrathecal infusion of the same culture medium not containing no BDNF.To induce Parkinsonian syndromcs, a total of 1mg/kg MPTP was administered intravenously to each monkey in both BDNF and non-BDNF groups. Neurological signs in the monkeys were monitored for 2 weeks and scored according to the monkey Parkinsonism rating scale ; histological changes in the substantia nigra were evaluated after the 2-week observation period.The BDNF-treated animals remained asymptomatic during the first week and showed mild parkinsonism during the second week, whereas the non-BDNF group showed typical Parkinsonian syndrome during the first week, with deterioration in the second week. Histological damage in the substantia nigra correlated well with the clinical features. Severe neuronal cell loss in the substantia nigra was observed in animals with severe Parkinsonism(those in the non-BDNF group), while significantly less damage was observed in this region in the BDNF group.These findings suggest that BDNF may have a preventive effect on the neurological syndrome and the histological damage of the substantia nigra in MPTP-induced Parkinsonism in monkeys.
在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的猴帕金森模型中,研究鞘内输注脑源性神经营养因子(BDNF)的作用。9只日本猴子随机分为三组:未治疗对照组(n=3);BDNF组,n=3;非bdnf组(n=3)。BDNF组连续鞘内输注含有10杯BDNF蛋白的细胞培养基10 ml;而非BDNF组则在鞘内输注不含BDNF的相同培养基。为了诱导帕金森综合征,在BDNF组和非BDNF组中,每只猴子静脉注射1mg/kg MPTP。监测2周后,根据猴帕金森病评定量表进行评分;观察2周后观察黑质组织学变化。bdnf治疗的动物在第一周无症状,第二周表现出轻度帕金森病,而非bdnf组在第一周表现出典型的帕金森病,第二周病情恶化。黑质组织学损伤与临床表现密切相关。在患有严重帕金森病的动物(非BDNF组)中,观察到黑质中严重的神经元细胞损失,而BDNF组在该区域观察到的损伤明显较小。这些发现提示BDNF可能对mptp诱导的帕金森猴神经系统综合征和黑质组织学损伤具有预防作用。

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tetsuya Tsukahara: "Effect of Brain-Derived Newrotrophic Factor(BDNF)on MPTPA-induced Parkinsontan Monkey" Soc.Neuroscl.Abstr(Part 1.). 19. 275 (1993)
Tetsuya Tsukahara:“脑源性新生营养因子 (BDNF) 对 MPTPA 诱导的帕金森猴的影响”Soc.Neuroscl.Abstr(第 1 部分)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Tanaka,T.Tsukahara,etal: "Effect of Nerve Growth Factor on Delayed Neuronal Derth After Cerebral Ischemia." Acta.Neuro chirargica(Wien). 129. 64-71 (1994)
K.Tanaka、T.Tsukahara 等人:“神经生长因子对脑缺血后延迟神经元睡眠的影响”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Tsukahara,et al: "Effects of Brain-Derived Neurotrophic Factor(BDNF) on 1-Methy1-4-phanyl-1,2,3,6-Tetrahydropyridine (MPTP)-Tnduced Parkinsonism in Morkeys." Neurosuvgerp (submitted).
T.Tsukahara 等人:“脑源性神经营养因子 (BDNF) 对 1-Methy1-4-phanyl-1,2,3,6-四氢吡啶 (MPTP) 诱发的莫基帕金森症的影响”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Tsukahara, M.Hashimoto et al.: "Increase of mRNA of BDNF and its promotors after transient forebrain ischemia in the rat braind" Soc.Neurosci Abstr. 20 : Part1.257. 16 (1994)
T.Tsukahara、M.Hashimoto 等人:“大鼠大脑短暂前脑缺血后 BDNF 及其启动子的 mRNA 增加”Soc.Neurosci Abstr。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Tsukahara,Y.Yonekawa,K.Tanaka,etal: "The Role of Brain-derived Neuro trophic Factor(BDNF)in Transient Forebrain Ischemia the Rat Brain" Neurosurgery. 34. 322-331 (1994)
T.Tsukahara、Y.Yonekawa、K.Tanaka 等人:“脑源性神经营养因子 (BDNF) 在大鼠短暂前脑缺血中的作用”神经外科。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUKAHARA Tetsuya其他文献

TSUKAHARA Tetsuya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUKAHARA Tetsuya', 18)}}的其他基金

Treatment of Neurodegenerative disease with recombinent cells
用重组细胞治疗神经退行性疾病
  • 批准号:
    04557064
  • 财政年份:
    1992
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了